PrimeVigilance and Prudentia Group Unite

PrimeVigilance and Prudentia Group Unite to Deliver End-to-End Pharmacovigilance and Safety Database Solutions

 

London, UK – [September 1, 2025] PrimeVigilance, a leading provider of global pharmacovigilance (PV) and medical information services, is pleased to announce the acquisition of Prudentia Group. This strategic move combines PrimeVigilance’s deep domain expertise with Prudentia’s renowned capabilities in PV technology, process, and management consulting—establishing a next-generation safety partner equipped to support integrated safety, compliance, and system transformations.

With nearly two decades of specialized experience, PrimeVigilance has built a reputation for delivering high-quality, scalable pharmacovigilance solutions to life sciences companies worldwide. The acquisition of Prudentia Group significantly enhances PrimeVigilance’s ability to optimize operations and connect clients with the right safety solutions.

“We’ve always believed in simplifying complexity for our clients,” said Vladimir J. Laguerre, Managing Partner, Prudentia Group. “By joining PrimeVigilance, we’re elevating that mission. Together, we are transforming how life sciences companies approach safety, compliance, and digital innovation.”

 

Bridging PV Strategy, Technology, and Execution

Operating under the principle of providing simple solutions to complex problems, PrimeVigilance now offers an expanded service portfolio through its PVConsult™ and PVIntegrate™ divisions. These units guide clients through the full journey of integration and centralization—from initial planning and execution to long-term operational support.

“What sets us apart is our ability to bridge operational pharmacovigilance expertise with the latest PV technology,” said Sally Amanuel, President of PrimeVigilance. “This acquisition creates a true strategy-to-execution partner for our clients. From global ICSR management to benefit–risk assessment and signal detection, we provide the full spectrum of safety services—all under one roof, for every stage of drug development.”

 

A New Standard in Safety System Transformation

The integration with Prudentia enables PrimeVigilance to accelerate digital transformation across the pharmacovigilance landscape. Together, the organizations now offer unmatched precision, speed, and compliance in PV innovation, implementation, and long-term support.

 

About PrimeVigilance
PrimeVigilance, an Ergomed company, is a global leader in pharmacovigilance and medical information services. With a team of international safety experts, the company supports more than 500 clients—from emerging biotechs to top 10 pharma—across more than 160 countries.

About Prudentia Group
Prudentia Group is a recognized expert in PV managed services and consulting. Now part of PrimeVigilance, Prudentia brings deep technological expertise to an already robust safety offering.